![Vanessa Ragaglia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vanessa Ragaglia
Corporate Officer/Principal chez Garnet BioTherapeutics, Inc.
Profil
Vanessa Ragaglia is currently working as the Lab Director at Celebration Stem Cell Centre and as the Vice President-Research at Garnet BioTherapeutics, Inc. She completed her undergraduate degree at Trinity College (Connecticut) and her doctorate degree at The Ohio State University College of Medicine.
Postes actifs de Vanessa Ragaglia
Sociétés | Poste | Début |
---|---|---|
Garnet BioTherapeutics, Inc.
![]() Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/01/2000 |
Celebration Stem Cell Centre | Corporate Officer/Principal | - |
Formation de Vanessa Ragaglia
Trinity College (Connecticut) | Undergraduate Degree |
The Ohio State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Garnet BioTherapeutics, Inc.
![]() Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
Celebration Stem Cell Centre |